入住重症监护室(ICU)的新冠肺炎患者的真菌感染与死亡率增加无关。

IF 1.8 Q3 CRITICAL CARE MEDICINE Critical Care Research and Practice Pub Date : 2023-09-09 eCollection Date: 2023-01-01 DOI:10.1155/2023/4037915
James Ainsworth, Peter Sewell, Sabine Eggert, Keith Morris, Suresh Pillai
{"title":"入住重症监护室(ICU)的新冠肺炎患者的真菌感染与死亡率增加无关。","authors":"James Ainsworth,&nbsp;Peter Sewell,&nbsp;Sabine Eggert,&nbsp;Keith Morris,&nbsp;Suresh Pillai","doi":"10.1155/2023/4037915","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Fungal infection is a cause of increased morbidity and mortality in intensive care patients. Critically unwell patients are at increased risk of developing invasive fungal infections. COVID-19 patients in the intensive care unit (ICU) may be at a particularly high risk. The primary aim of this study was to establish the incidence of secondary fungal infections in patients admitted to the ICU with COVID-19. Secondary aims were to investigate factors that may contribute to an increased risk of fungal infections and to calculate the mortality between fungal and nonfungal groups.</p><p><strong>Methods: </strong>We undertook a retrospective observational study in a tertiary ICU in Wales, United Kingdom. 174 patients admitted with COVID-19 infection from March 2020 until May 2021 were included. Data were collected through a retrospective review of patient's clinical notes and microbiology investigation results obtained from the online clinical portal.</p><p><strong>Results: </strong>81/174 (47%) COVID-19 patients developed fungal infections, 93% of which were Candida species, including <i>Candida albicans</i> (88%), and 6% had an Aspergillus infection. Age and smoking history did not appear to be contributing factors. The nonfungal group had a significantly higher body mass index (33 ± 8 vs. 31 ± 7, <i>p</i>=0.01). The ICU length of stay (23 (1-116) vs. 8 (1-60), <i>p</i> < 0.001), hospital length of stay (30 (3-183) vs. 15 (1-174) ± 7, <i>p</i> < 0.001), steroid days (10 (1-116) vs. 4 (0-28), <i>p</i>=0.02), and ventilation days (18 (0-120) vs. 2 (0-55), <i>p</i> < 0.001) were significantly higher in the fungal group. The mortality rate in both groups was similar (51% vs. 52%). The Kaplan-Meier survival analysis showed that the fungal group survived more than the nonfungal group (log rank (Mantel-Cox), <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Secondary fungal infections are common in COVID-19 patients admitted to the ICU. Longer treatment with corticosteroids, increased length of hospital and ICU stay, and greater length of mechanical ventilation significantly increase the risk of fungal infections. Fungal infection, however, was not associated with an increase in mortality.</p>","PeriodicalId":46583,"journal":{"name":"Critical Care Research and Practice","volume":"2023 ","pages":"4037915"},"PeriodicalIF":1.8000,"publicationDate":"2023-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505078/pdf/","citationCount":"0","resultStr":"{\"title\":\"Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU).\",\"authors\":\"James Ainsworth,&nbsp;Peter Sewell,&nbsp;Sabine Eggert,&nbsp;Keith Morris,&nbsp;Suresh Pillai\",\"doi\":\"10.1155/2023/4037915\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Fungal infection is a cause of increased morbidity and mortality in intensive care patients. Critically unwell patients are at increased risk of developing invasive fungal infections. COVID-19 patients in the intensive care unit (ICU) may be at a particularly high risk. The primary aim of this study was to establish the incidence of secondary fungal infections in patients admitted to the ICU with COVID-19. Secondary aims were to investigate factors that may contribute to an increased risk of fungal infections and to calculate the mortality between fungal and nonfungal groups.</p><p><strong>Methods: </strong>We undertook a retrospective observational study in a tertiary ICU in Wales, United Kingdom. 174 patients admitted with COVID-19 infection from March 2020 until May 2021 were included. Data were collected through a retrospective review of patient's clinical notes and microbiology investigation results obtained from the online clinical portal.</p><p><strong>Results: </strong>81/174 (47%) COVID-19 patients developed fungal infections, 93% of which were Candida species, including <i>Candida albicans</i> (88%), and 6% had an Aspergillus infection. Age and smoking history did not appear to be contributing factors. The nonfungal group had a significantly higher body mass index (33 ± 8 vs. 31 ± 7, <i>p</i>=0.01). The ICU length of stay (23 (1-116) vs. 8 (1-60), <i>p</i> < 0.001), hospital length of stay (30 (3-183) vs. 15 (1-174) ± 7, <i>p</i> < 0.001), steroid days (10 (1-116) vs. 4 (0-28), <i>p</i>=0.02), and ventilation days (18 (0-120) vs. 2 (0-55), <i>p</i> < 0.001) were significantly higher in the fungal group. The mortality rate in both groups was similar (51% vs. 52%). The Kaplan-Meier survival analysis showed that the fungal group survived more than the nonfungal group (log rank (Mantel-Cox), <i>p</i> < 0.001).</p><p><strong>Conclusion: </strong>Secondary fungal infections are common in COVID-19 patients admitted to the ICU. Longer treatment with corticosteroids, increased length of hospital and ICU stay, and greater length of mechanical ventilation significantly increase the risk of fungal infections. Fungal infection, however, was not associated with an increase in mortality.</p>\",\"PeriodicalId\":46583,\"journal\":{\"name\":\"Critical Care Research and Practice\",\"volume\":\"2023 \",\"pages\":\"4037915\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2023-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505078/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Care Research and Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2023/4037915\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care Research and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2023/4037915","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

摘要

引言:真菌感染是重症监护患者发病率和死亡率增加的原因之一。严重不适的患者发生侵袭性真菌感染的风险增加。重症监护室(ICU)的新冠肺炎患者可能面临特别高的风险。本研究的主要目的是确定新冠肺炎入住ICU的患者继发真菌感染的发病率。次要目的是调查可能导致真菌感染风险增加的因素,并计算真菌组和非真菌组的死亡率。方法:我们在英国威尔士的一家三级重症监护室进行了一项回顾性观察性研究。包括2020年3月至2021年5月收治的174名新冠肺炎感染患者。通过对患者的临床记录和从在线临床门户网站获得的微生物学调查结果进行回顾性审查来收集数据。结果:81/174(47%)新冠肺炎患者发生真菌感染,其中93%为念珠菌,包括白色念珠菌(88%),6%为曲霉菌感染。年龄和吸烟史似乎不是促成因素。非真菌组的体重指数明显较高(33 ± 8对31 ± ICU住院时间(23(1-116)vs.8(1-60),p<0.001),住院时间(30(3-183)vs.15(1-174) ± 7,p<0.001)、类固醇天数(10(1-116)对4(0-28),p=0.02)和通气天数(18(0-120)对2(0-55),p<001)在真菌组中显著较高。两组的死亡率相似(51%对52%)。Kaplan-Meier生存率分析显示,真菌组的生存率高于非真菌组(log-rank(Mantel-Cox),p<0.001)。结论:在入住ICU的新冠肺炎患者中,继发性真菌感染很常见。皮质类固醇治疗时间更长,住院时间和ICU住院时间更长,机械通气时间更长,都会显著增加真菌感染的风险。然而,真菌感染与死亡率的增加无关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Fungal Infections Are Not Associated with Increased Mortality in COVID-19 Patients Admitted to Intensive Care Unit (ICU).

Introduction: Fungal infection is a cause of increased morbidity and mortality in intensive care patients. Critically unwell patients are at increased risk of developing invasive fungal infections. COVID-19 patients in the intensive care unit (ICU) may be at a particularly high risk. The primary aim of this study was to establish the incidence of secondary fungal infections in patients admitted to the ICU with COVID-19. Secondary aims were to investigate factors that may contribute to an increased risk of fungal infections and to calculate the mortality between fungal and nonfungal groups.

Methods: We undertook a retrospective observational study in a tertiary ICU in Wales, United Kingdom. 174 patients admitted with COVID-19 infection from March 2020 until May 2021 were included. Data were collected through a retrospective review of patient's clinical notes and microbiology investigation results obtained from the online clinical portal.

Results: 81/174 (47%) COVID-19 patients developed fungal infections, 93% of which were Candida species, including Candida albicans (88%), and 6% had an Aspergillus infection. Age and smoking history did not appear to be contributing factors. The nonfungal group had a significantly higher body mass index (33 ± 8 vs. 31 ± 7, p=0.01). The ICU length of stay (23 (1-116) vs. 8 (1-60), p < 0.001), hospital length of stay (30 (3-183) vs. 15 (1-174) ± 7, p < 0.001), steroid days (10 (1-116) vs. 4 (0-28), p=0.02), and ventilation days (18 (0-120) vs. 2 (0-55), p < 0.001) were significantly higher in the fungal group. The mortality rate in both groups was similar (51% vs. 52%). The Kaplan-Meier survival analysis showed that the fungal group survived more than the nonfungal group (log rank (Mantel-Cox), p < 0.001).

Conclusion: Secondary fungal infections are common in COVID-19 patients admitted to the ICU. Longer treatment with corticosteroids, increased length of hospital and ICU stay, and greater length of mechanical ventilation significantly increase the risk of fungal infections. Fungal infection, however, was not associated with an increase in mortality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Critical Care Research and Practice
Critical Care Research and Practice CRITICAL CARE MEDICINE-
CiteScore
3.60
自引率
0.00%
发文量
34
审稿时长
14 weeks
期刊最新文献
The Hemodynamic Management and Postoperative Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Prospective Observational Study. Efficacy of COVID-19 Treatments in Intensive Care Unit: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Assessment of Satisfaction Levels Among Families of Intensive Care Unit Patients in Saudi Arabia: A Cross-Sectional Study. Serum Concentration at 24 h With Intensive Beta-Lactam Therapy in Sepsis and Septic Shock: A Prospective Study: Beta-Lactam Blood Levels in Sepsis. Assessing the Impact of Simulation-Based Learning on Student Satisfaction and Self-Confidence in Critical Care Medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1